Telix Pharmaceuticals Limited today announces that it has received a positive decision on the Marketing Authorization ...

Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.

The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, "Toripalimab has made significant strides in its ...

The Food and Drug Administration issued marketing granted orders to 20 Zyn nicotine pouch products. The announcement on ...

Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...

IMPACT Therapeutics ('IMPACT'), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...

The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

ORLANDO, FLORIDA / ACCESS Newswire / January 17, 2025 / (NYSE American:UMAC), a leading innovator in drone technology with a current focus on U.S. based manufacturing and marketing of drone parts is ...

The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicoti ...